ducible results with high precision at an appreciably lower cost. The reactors are stable to continued or intermittent use forat leastthree months or for 4000 tests.
AdditIonal Keyphrases enzymatic meThods . gout diagnosis #{149} intermethod comparison #{149} economics of laboratory operation
Uric acid determination is essential in the diagnosis of gout, a primary hyperuricemiaknown to affect at least 1 to 2% of the population in West Germany (1); of these, only 2% show normal values for serum uric acid (2) . Moreover, hyperuricemia is a major risk factor in the pathogenesis of atherosclerosis and may induce renal diseases by sedimentation of uric acid within the kidneys.
Besides the primary pathological situations, concentrations of uric acid in the serum may also increase in diseases such as leukemia and polycythemia in which cell turnover is increased by therapy with x-rays and cytostatic therapy. Long-time therapy with diuretic drugs also creates a secondary hyperuricemia.
Until recently, serum uric acid has been routinely measured in clinical laboratories by methods that depend on the reduction of alkaline phosphotungstate, methods with which a constantly increasing number of substances, such as normal metabolites or drugs or their breakdown products, are found to interfere.
Unease (urate oxidase, EC 1.7.3.3) a highly specific enzyme that converts uric acid to allantoin and H202, is now most commonly used to estimate the metabolite, but determinations made with enzymes in solution often are relatively expensive. Uricase procedures for uric acid may be mechanized by essentially the following approaches: (a) by measuring ultraviolet absorption at 293 nm before and after uricase action (3); (b) by colorimetry of reducing substances before and after treatment with uricase, followed by a Cu2-alkanolamine reagent as the indicator, which forms a neocuproine complex (4); and (c) by methods that depend on the detection of H202 from the uricase reaction. In thesemethods,H202 is furthersplit by the actionof eitherperoxidaseor catalase
Filippusson et al. (10) coupled unease onto nylon powder and used this in a continuous-flow system for analysis, and Nanjo and Guilbault (11) incorporated immobilized unease into a platinum electrode which was part of a continuous-flow analytical system.
The onset of mechanization and the increasing use of enzymes in routine testing has become possible only because of a reduction in cost. As Sundaram et al. (12) showed in the ease of serum urea determination, the cost of operation can be dramatically reduced by use of an immobilized-enzyme nylon tube reactor3 made by immobilizing unease onto the inside surface of a thin nylon tube. These reactors are not only suitable for repeated use, but by virtue of their tubular structure they are ideally suited for incorporation into the flow system of a continuous-flow analytical system of the Technicon type.
This paper describes a method of preparing an immobilized-uricase nylon-tube reactor for the routine determination of uric acid in serum.
Materials and Methods

Apparatus
In our preliminary trials we used a "Vanioperpex" penstaltic pump (LKB Produkter, Bromma, Sweden) to control the rate of flow of substrate through the unease reactor. For the clinical trials we used a Technicon AutoAnalyzer II (Technicon Instruments Corp., Tarrytown, N.Y. 10591). For brevity, it will be also referred to here as "uricase reactor."
Materials
Nylon-PE!-Uricase nophenazone from Boehringer Mannheim, the latter being taken from the unease-PAP (peroxidase, 4-aminophenazone, dichlorophenol) test kit. 
Folin-Denis reagent:
This was supplied by E. Merck
GmbH. The working solution, obtained by 10-fold dilution, is stable at room temperature for as long as one year when stored in a brown bottle.
Sodium carbonate:
A 100 g/liter solution was stored in an alkali-resistant bottle.
Sodium tungstate:
A 100 gfliter solution, prepared from Na2WO4.2H20. 
Uric acid stock solution:
Prepare a 1 g/liter solution by dissolving 0.1 g of uric acid in 25 ml of a 4 gfliter solution of lithium carbonate, warm to 50-60 #{176}C, and dilute to 100 ml. Store at 4 #{176}C. This solution should be prepared weekly.
For clinical trials with the unease reactor, we used tnis-(hydnoxymethyl)azninomethane citrate buffer (75 mmol/liter, pH 9. The porcine liver enzyme is supplied as a 2 g/liter solution in 500 g/liter glycerin, which is first dialyzed against pH 7 phosphate buffer at 0#{176}C. However, the Aspergillus enzyme, a lyophilized powder, is dissolved directly in the coupling buffer.
Nylon-PEI copolymer is made by the method of Sundaram and Apps (13) wherein a 10 g/liter dilution in bicarbonate buffer, pH 9.4,0.1 mol/liter of stock solution supplied by Serva GmbH (69 Heidelberg, W. Germany) is pumped through or filled into the derivatized nylon tube at room temperature for 4 h. The tube is then washed well with de-ionized water and filled with a freshly made solution of glutaraldehyde (a 10-fold dilution of a 250 g/liter solution) in bicarbonate buffer (0.1 mmol/liter, pH 9.4). After 40 mm at room temperature, the tube was again washed well with water and immediately filled with a 2 gluten solution of porcine liver unease or a 0.5 g/liter NaCl and with water to remove any adsorbed protein.
Coupling of the enzyme directly to the alkylated nylon followed virtually the same procedure described above: the alkylated tube was filled with the enzyme solution and left overnight before washing as described for uneaseby Sundaram et al. (12) . Figure 1 depicts the chemical reactions involved in preparing unease reactors by direct coupling to 0-alkylated nylon and by cross linking to nylon-PEI copolymer. It has been assumed that the bond between an amino group and an aldehyde group in glutaraldehyde leads to the formation of a Schiff's base as shown in Figure 1 . More recent work (14) , however, suggests that the addition of amino groups of protein to the unsaturated centers formed by initial polymerization of glutaraldehyde may be favored. These findings are supported by investigations in our laboratory (15) showing that polymers such as proteins, cross-linked with dialdehydes to solid supports, are quite stable even without borohydnide reduction.
Analytical Methods
Preliminary trials: Uric acid was measured by two methods:
(a) By passing a 1 mmol/liter solution of uric acid in phosphate buffer (0.1 mol/liten) through the unease reactor at a flow rate of 0.32 ml/min. We measured the absorbanceof the initial solution and the effluent from the reactor at 293 nm, using a coefficient of a molar absorptivity of 1220 liter mol' cm1 for uric acid at pH 7 in the calculations. The solution must be at a specific pH because there is a spectral shift with change of pH. Solutions must be fresh because uric acid is unstable in these buffers.
(b) By the phosphotungstic acid assay with use of FolinDenis reagent (16, 17) . In a typicalanalysis, 0.1 ml of substrate or effluent from a unease reactor was dilutedto 2.5 ml with water and 0.5 ml of a 100 g/liter Na2CO3 solution was added, followed by 0.5 ml of a 10-fold diluted Folin-Denis reagent from the commercially available solution. After 30 mm at Routine mechanized analysis with a Technicon AutoAnalyzer AA II. The flow diagram for this determination is given in Figure 2 for the unease-PAP method with use of a unease reactor and in Figure 3 for the same method with unease in solution.
The latter was modified from the original method given by Klose et al. (18) , yielding an improved washout.
In each flow diagram, after the addition of dichlorophenol and aminophenazone all connections were made of glass.
The 3-methyl-benzthiazolin-2-on-hydrazone/dimethylaniline (MBTH/DMA) method for determining uric acid was carried out on one channelof a Technicon SMA 12 analyzer according to the method proposed by Technicon (19) .
During the reaction the enzyme reactors were kept at room temperature; they were stored at 4 #{176}C, filled with 0.1 mol/liter phosphate buffer, pH 7.0. Calibrations in all cases were done with commercially available control sera. a deviation well within 2%. This is in the range of concentration generally encountered in sera from patients. it is io noteworthy that this range of concentration is well within the Kmapp. for the unease reactor, which assures that the operational conditions are within the linear range, that ms, second order-or as in this ease because the enzyme is in large excess, it is the "pseudo-first-order" range. Figure 4 shows the effect of flow-rate of substrate on the activity of the unease reactor at pH 7 with a 1-meter-long unease reactor. In a detecting device that is part of a flowthrough system, specific activity depends upon the length of time the substrate is in contact with the immobilized enzyme.
Thus activity is inversely proportional to flow rate. In our initial investigations we compared uric acid estimation in sera with the unicase reactor and with the FolinDenis method (Table 1) . Measuring uric acid by the change in absorbance at 293 nm after unease action is impractical on a routine basis because commercially available continuousflow analyzers generally do not include a detecting devicefor this wavelength. Despite this drawback, the initial laboratory trials looked promising and encouraged further clinical investigation.
Besides the direct determination of uric acid by measurement of absonbance at 293 nm, several color-producing methods are available. Older chemical methods should be eschewed because of their lack of specificity. The often-used
Results and Discussion
method of Kageyama (5) that results in the formation of 3,5-diacetyl-1,4-dihydrolutidine as the colored end-product The pH/activity profiles of unease in solution and the urnis not practicable on continuous-flow systems because of the case reactor were very similar between pH 7.5 to 9.5, with no long incubation times necessary. change within this range. However, the immobilized unease A recently introduced method of Klose et al. (18) in which shows nearly twice the activity at pH 7.0 as compared with dichlorophenol and 4-aminophenazone are used is commerthat of pH 7.5 to 9.5. The Kmapp. for the inimobilized enzyme cially referred to as the "Unease-PAP" method. In it, a purple Eachaverage value Is for20 determinatIons.
dye is formed for which the Am. is 508 nm. Since this method can be easily adapted to continuous-flow systems it was chosen as the method of detection for the unease reactor described in this study. It was compared to the same method with uncase in solution. The unease-reactor PAP method was also compared to a unease-solution method adaptable to continuous-flow systems in which a green color is produced by
MBTH and DMA (9).
With use of two unease reactors of 1-meter length, each having a specific activity of 64 and 47 nmol/meter per minute, respectively, at a flow-rate of 0.33 ml/min, substrate breakdown was linear up to 12 mg of uric acid per liter.
The carryover between a pathological concentration of 98 mg/liter and a normal value of 45 mg/liter amounted to 2.4 mg/liter or 5.5% as the average of 20 determinations. This is reasonable, but not quite as good as with the unease method in solution, even though only 40 samples per hour with a sample/wash ratio of 9/1 compared to 50 samples in solution were analyzed. The reason for this may be an increased carryover within the unease reactor. Increased specific activity of the immobilized-enzyme nylon-tube reactor should make it possible to shorten the reactor and thus eliminate this problem. The precision of this new method is good for different control sera with high and low values ( Table 2) .
The correlation between the two different PAP methods for 255 sera, with unease in solution and a unease reactor, is shown by a regression analysis in Figure 5 . This correlation may be improved when ascorbate oxidase (EC 1.10.3.3) is also added to the buffer in the enzyme-reactor method, as it is to the commercially available test-pack with unease in solution, to remove interfering ascorbate. Investigations are in progress to find out whether ascorbate oxidase can alsobe immobilized, thus improving the system by integrating an ascorbate oxidase reactor into the flow of the diluted sample.
We also attempted to immobilize peroxidase on the tube, but when the dye along with the substrate was perfused through the tube for the detection of H202, the enzyme was inhibited. Otherwise the immobilized enzyme was active. The correlation between the unicase reactor PAP method and the MBTH/DMA method is not quite as good, as is shown by regression analysis (Figure 6 ). We used 255 patients' sera in this comparison. These results are probably not a reflection on the efficiency of the unicase reactor but rather more attributable to differences in the PAP and the MBTHIDMA methods because there are similar differences when the same two methods with unease in solution are inter-compared.
Operational and Storage Stability
The unease reactors are very stable, either in continual or intermittent use.The activity after intermittent use for three months was reduced to about 50%, still active enough for further routine use. Figure 7 shows the decline in activity on continued use for 23 days, with 150 to 200 samples being assayed every day. In these clinical trials the tubes were at room temperature during daily routine use and stored at 4 #{176}C overnight. Under these conditions the activity of the tubes also N&imber of days ri continous use Fig. 7 . Decay curve 0-0 and0-0 represent themonitoring of activity of two unease reactors made with nylon-PEI copolymertubes duringcontinuousoperation In the clinic, over 4000 tests each declined to about 50%. More than 4000 samples were assayed with a 2-m tube of the activity mentioned above.
We conclude that immobilized-enzyme nylon-tube reactors made with unease and integrated into the flow system of a continuous-flow analyzer can be used routinely in hospital laboratories. Analysis costs can be dramatically reduced by this method. After 4000 tests, the activity left in the unease reactors was still adequate, but already at this stage the cost of enzyme alone, which is responsible for most of the overall cost of a test, had been reduced 10-fold as compared to the correspondingsolution method. The preparation, storage, and use of these reactors are simple enough to recommend their widespread acceptance.
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